Guadalajara/Cuenca, 11 October 2026 — The team from the Paediatrics Department at the Hospital Universitario de Guadalajara has received the award for best presentation at the 29th annual meeting of the Sociedad de Pediatría de Madrid y Castilla-La Mancha (SPMyCM) in Cuenca. The award went to a study assessing the treatment of eosinophilic oesophagitis in paediatric care in the province of Guadalajara over a ten-year period.
According to the regional health authority and the organisers, the paper won in a final featuring ten entries. It was judged on scientific quality, relevance to clinical practice and presentation of the results. The study focuses on children and adolescents’ clinical response to an oral, viscous formulation prepared by the hospital pharmacy of Budesonide. The authors draw practical guidance from this for the use of individualised preparations.
The eosinophilic oesophagitis is a chronic inflammatory disease of the oesophagus that can cause swallowing difficulties and nutrition-related problems in children as well. Topical steroids such as budesonide, prepared in a consistency suitable for the oesophagus, are among established treatment options alongside dietary approaches. The award-winning study draws on clinical data from the province of Guadalajara and reflects care practices documented consistently over a number of years.
The hospital says the award reinforces the role of the hospital pharmacy in individualised dosage forms and highlights paediatric research within the region’s public health service. The hospital is run by the regional health service SESCAM. The Sociedad de Pediatría de Madrid y Castilla-La Mancha organises the annual meeting as a forum for paediatricians from both regions to exchange expertise, and regularly awards prizes for papers.
The published brief names the paper and the award, but does not list the authors or provide detailed results. No information was provided on the number of cases, methodology, follow-up or potential conflicts of interest. Statements about the efficacy and safety of the budesonide formulation used are therefore based on the summary provided by the organisers and the hospital. Further information should be requested from the Sociedad de Pediatría de Madrid y Castilla-La Mancha or the Hospital Universitario de Guadalajara.
The conference took place in Cuenca; the award-winning paper is rooted in care practice in the province of Guadalajara. The story is therefore primarily regional in Castile-La Mancha scope.
Editor: Mira Cadena (Article created with AI assistance).